Genetic and non-genetic factors affecting the visual outcome of ocular Behcet’s disease

2013 ◽  
Vol 74 (10) ◽  
pp. 1363-1367 ◽  
Author(s):  
Eun Ha Kang ◽  
Jun Won Park ◽  
Chaerin Park ◽  
Hyeong Gon Yu ◽  
Eun Bong Lee ◽  
...  
2018 ◽  
Vol 103 (1) ◽  
pp. 83-87 ◽  
Author(s):  
Ammr Alghamdi ◽  
Bahram Bodaghi ◽  
Chloé Comarmond ◽  
Anne Claire Desbois ◽  
Fanny Domont ◽  
...  

BackgroundThe neuro-ophthalmological manifestations of Behcet’s disease (BD) are rare, and data regarding their characteristics and outcome are lacking.ObjectiveTo report prevalence, main characteristics and outcome of neuro-ophthalmological manifestations in BD.Patients and methodsThis is a retrospective monocentric study of 217 patients diagnosed with neuro-Behçet’s disease (NBD), of whom 29 (13.3%) patients presented with neuro-ophthalmological manifestations (55% of men and mean±SD age of 26±8 years). All patients underwent a detailed ophthalmological examination and were followed up in the internal medicine and the ophthalmology departments.ResultsNeuro-ophthalmological manifestations were the first presentation of BD in 45% of patients and developed later in the course of the disease in 55% of patients. They are divided into parenchymal (PM) and non-parenchymal (NPM)-related manifestations in, respectively, 13 patients (45%) and 16 patients (55%). PM included papillitis in seven patients (53.8%), retrobulbar optic neuritis in four patients (30.8%) and third cranial nerve palsy in two patients (15.4%). NPM included papilloedema related to cerebral venous thrombosis in all 16 patients, of whom 6 patients (37.5%) had sixth cranial nerve palsy. At initial examination, 93.1% of patients had visual alterations, including mainly decreased visual acuity visual field defects and/or diplopia. All patients were treated with corticosteroids and 79% of patients received immunosuppressive agents. After treatment, the visual outcome improved or stabilised in 66.7% of patients while it worsened in 33.3. The mean±SD logarithm of the minimum angle of resolution visual acuity improved from 0.4±0.3 at diagnosis to 0.2±0.3 after therapy. 10.3% and 3.4% of patients were legally blind at diagnosis and after therapy, respectively.ConclusionNeuro-ophthalmological manifestations of BD represented 13% of NBD. They could be potentially severe and disabling. Prompt treatment is the key factor in improving visual outcome.


Behçet’s disease (BD) is a chronic multisystem inflammatory disease characterized mainly by recurrent oral ulcers, ocular inflammation, genital ulcers, and skin lesions, presenting with remission and exacerbations. The pathogenesis of BD has not been fully elucidated since it has a broad spectrum of phenotypic heterogeneity and complex immunopathogenesis. BD has been considered that both environmental and genetic factors contribute to its onset and development. Recent advances in molecular biology and genetics show us that particular genes encompass both innate and adaptive immunity, and confirm the importance of the predominant polarization towards helper T cell (Th)1 versus Th2 cells, and the involvement of Th17 cells in BD.


2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Samuel J. Shenoi ◽  
Erich J. Baker

Abstract Objective Behçet’s disease (BD) is a multisystem inflammatory disease that affects patients along the historic silk road. Thus far, the pathogenesis of the disease has proved elusive due to the complex genetic interactions of the disease. In this paper, we seek to clarify the genetic factors of the disease while also uncovering other diseases of interest that present with a similar genotype as BD. Results To do this, we employ a convergent functional genomics approach by leveraging the hierarchical similarity tool available in Geneweaver. Through our analysis, we were able to ascertain 7 BD consensus genes and 16 autoimmune diseases with genetic overlap with BD. The results of our study will inform further research into the pathogenesis of Behçet’s disease.


1993 ◽  
Vol 14 ◽  
pp. 47s
Author(s):  
KF. Tabbara ◽  
PS. Chavis ◽  
S. Al Balla ◽  
AK. Al-Momen

2015 ◽  
Vol 35 (12) ◽  
pp. 2103-2107 ◽  
Author(s):  
Nilay Ugurlu ◽  
Selen Bozkurt ◽  
Ali Bacanli ◽  
Ayse Akman-Karakas ◽  
Soner Uzun ◽  
...  

1995 ◽  
Vol 3 (2) ◽  
pp. 99-106 ◽  
Author(s):  
J. Palmares ◽  
J. Castro-correia ◽  
M. F. Coutinho ◽  
D. Araújo ◽  
L. Delgado

Eye ◽  
2009 ◽  
Vol 23 (11) ◽  
pp. 2034-2041 ◽  
Author(s):  
M Kramer ◽  
R Amer ◽  
M Mukamel ◽  
M Snir ◽  
T Jaouni ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Marina Mesquida ◽  
Blanca Molins ◽  
Victor Llorenç ◽  
Maite Sainz de la Maza ◽  
María Victoria Hernandez ◽  
...  

The aim of the present study was to determine the serum cytokine profile and levels of high sensitivity C-reactive protein (hsCRP) in patients with uveitis associated with Behçet’s disease (BD) and to compare them with those obtained from healthy control subjects. We determined the serum concentration of interferon-γ(IFN-γ), interleukin-1β(IL-1β), IL-12p70, IL-17A, tumor necrosis factor-α(TNF-α), and hsCRP in 13 patients with active uveitis associated to BD, 24 inactive BD patients, and 20 controls. In a subgroup of 10 active patients, a second serum sample was obtained when the disease was inactive. Cytokine profiles and hsCRP levels were correlated with disease activity, severity, complications, and visual outcome. Levels of IFN-γand TNF-αwere significantly increased in patients with active uveitis associated to BD compared to controls (P<0.05). IFN-γ, TNF-α, and hsCRP were significantly higher during active uveitis associated to BD compared to inactive disease (P<0.05). Furthermore, IL-17A was significantly increased in patients with active BD without pharmacological treatment compared to controls (P<0.05). No significant correlations were found with specific cytokine profiles and disease severity, visual outcome, or complications. In summary, increased serum levels of IFN-γ, TNF-α, IL-17A, and hsCRP were associated with active uveitis associated with BD and might serve as markers of disease activity.


2015 ◽  
Vol 100 (7) ◽  
pp. 990-994 ◽  
Author(s):  
Rie Tanaka ◽  
Hiroshi Murata ◽  
Mitsuko Takamoto ◽  
Kazuyoshi Ohtomo ◽  
Kimiko Okinaga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document